Comparison between CHADS2 and CHA2DS2-VASc score in a stroke cohort with atrial fibrillation

European Journal of Neurology

Volumn 20, Issue 4, 2013, Pages 623-628

  Giralt Steinhauer, E ^a   Cuadrado Godia, E ^b   Ois, A ^b   Jimenez Conde J ^b   Rodriguez Campello A ^b   Soriano, C ^b   Roquer, J ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

Author keywords

Anticoagulation; Atrial fibrillation; CHA2DS2 VASc; CHADS 2; Stroke

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

AGED; ALCOHOL CONSUMPTION; ARTICLE; BRAIN ISCHEMIA; CHA2DS2 VAS SCORE; CHADS2 SCORE; CLINICAL ASSESSMENT TOOL; COMPARATIVE STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANKIN SCALE; RISK FACTOR; THROMBOEMBOLISM; ALCOHOLISM; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; ELECTROCARDIOGRAPHY; HYPERTENSION; MIDDLE AGED; RISK ASSESSMENT; TRANSIENT ISCHEMIC ATTACK; VASCULAR DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALCOHOLISM; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CARDIOMYOPATHY, DILATED; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOEMBOLISM; VASCULAR DISEASES;

EID: 84875053904     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2012.03807.x     Document Type: Article

References (18)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
2. Gladstone DJ, Bui E, Fang J, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke 2009; 40: 235-240.
3. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
4. Schwammenthal Y, Bornstein N, Schwammenthal E, et al. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival [from the National Acute Stroke Israeli Survey (NASIS)]. Am J Cardiol 2010; 105: 411-416.
5. Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-1026.
6. Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010; 123: 638-645.e4.
7. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
8. Baruch L, Gage BF, Horrow J, et al. Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified? Stroke 2007; 38: 2459-2463.
9. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med 2010; 123: 484-488.
10. Giralt-Steinhauer E, Cuadrado-Godia E, Ois A, et al. CHA(2)DS(2)-VASc score and prognosis in ischemic strokes with atrial fibrillation. J Neurol 2011; 259: 745-751.
11. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58: 113-130.
12. Ois A, Cuadrado-Godia E, Jimenez-Conde J, et al. Early arterial study in the prediction of mortality after acute ischemic stroke. Stroke 2007; 38: 2085-2089.
13. Adams HP Jr, Davis PH, Leira EC, et al. Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 1999; 53: 126-131.
14. 2 score in a Mediterranean population. Rev Esp Cardiol 2008; 61: 29-35.
15. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
16. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011; 342: d124.
17. Djousse L, Levy D, Benjamin EJ, et al. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol 2004; 93: 710-713.
18. Kozlowski D, Budrejko S, Lip GY, et al. Lone atrial fibrillation: what do we know? Heart 2010; 96: 498-503.